{
  "paper_id": "PMC9284452",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284452/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Cumulative risk of contralateral breast cancer in TP53 carriers and non-carriers (patients with synchronous bilateral breast cancer were not included).",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32a/9284452/1887f7643a85/gr1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32a/9284452/1887f7643a85/gr1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32a/9284452/1887f7643a85/gr1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32a/9284452/1887f7643a85/gr1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32a/9284452/1887f7643a85/gr1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9284452/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32a/9284452/1887f7643a85/gr1.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The 10-year cumulative risk of contralateral breast cancer in TP53 carriers was significantly higher than that in non-carrier (17.9% vs 3.6%, hazard ratio (HR) = 7.0, 95% CI:3.3–14.9, P < 0.001) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The 10-year cumulative risk of contralateral breast cancer in TP53 carriers was significantly higher than that in non-carrier (17.9% vs 3.6%, hazard ratio (HR) = 7.0, 95% CI:3.3–14.9, P < 0.001) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The 10-year cumulative risk of contralateral breast cancer in TP53 carriers was significantly higher than that in non-carrier (17.9% vs 3.6%, hazard ratio (HR) = 7.0, 95% CI:3.3–14.9, P < 0.001) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 1,
    "claims_count": 3,
    "images_downloaded": 1,
    "tables_filtered": 33
  }
}